Paper36973270
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.
Jones SE and 1 other. Transl Psychiatry, 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system. Papers, record 36973270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36973270
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptor, Muscarinic M4 | Major topic |
| Psychotic Disorders | Major topic |
| Humans | |
| Cognition | |
| Receptor, Muscarinic M1 | |
| Cholinergic Agents |
Source PubMed
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7058341 | Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. | Science | 1982 | https://conductscience.org/library/papers/7058341 | PubMed |
| 2 | 19680823 | Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. | J Mol Neurosci | 2010 | https://conductscience.org/library/papers/19680823 | PubMed |
| 3 | 7766284 | Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. | Neuropsychopharmacology | 1995 | https://conductscience.org/library/papers/7766284 | PubMed |
| 4 | 15279046 | The global costs of schizophrenia. | Schizophr Bull | 2004 | https://conductscience.org/library/papers/15279046 | PubMed |
| 5 | 21704011 | Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21704011 | PubMed |
| 6 | 10785583 | Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. | Schizophr Res | 2000 | https://conductscience.org/library/papers/10785583 | PubMed |
| 7 | 11602695 | The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. | J Pharmacol Exp Ther | 2001 | https://conductscience.org/library/papers/11602695 | PubMed |
| 8 | 7909557 | Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. | J Pharmacol Exp Ther | 1994 | https://conductscience.org/library/papers/7909557 | PubMed |
| 9 | 32294346 | A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32294346 | PubMed |
| 10 | 11423097 | Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists. | Brain Res | 2001 | https://conductscience.org/library/papers/11423097 | PubMed |
| 11 | 23027411 | Cognitive impairment in schizophrenia. | Handb Exp Pharmacol | 2012 | https://conductscience.org/library/papers/23027411 | PubMed |
| 12 | 28887902 | Atropinic (anticholinergic) burden in antipsychotic-treated patients. | Fundam Clin Pharmacol | 2018 | https://conductscience.org/library/papers/28887902 | PubMed |
| 13 | 24442096 | Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. | Neuropsychopharmacology | 2014 | https://conductscience.org/library/papers/24442096 | PubMed |
| 14 | 31749647 | Domains of cognition and their assessment . | Dialogues Clin Neurosci | 2019 | https://conductscience.org/library/papers/31749647 | PubMed |
| 15 | 14702259 | Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. | Am J Psychiatry | 2004 | https://conductscience.org/library/papers/14702259 | PubMed |
| 16 | 25137629 | Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents. | ACS Chem Neurosci | 2014 | https://conductscience.org/library/papers/25137629 | PubMed |
| 17 | 8915035 | The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. | Dementia | 1996 | https://conductscience.org/library/papers/8915035 | PubMed |
| 18 | 16504943 | M1 receptors play a central role in modulating AD-like pathology in transgenic mice. | Neuron | 2006 | https://conductscience.org/library/papers/16504943 | PubMed |
| 19 | 30170114 | Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. | Neurobiol Dis | 2019 | https://conductscience.org/library/papers/30170114 | PubMed |
| 20 | 36528376 | Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial. | Lancet | 2022 | https://conductscience.org/library/papers/36528376 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42529039 | High perceived energy: exploring distinct patterns of energetic and cognitive functioning in older adults. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42529039 | PubMed |
| 41045433 | Efficacy and Safety of KarXT (Xanomeline-Trospium; Cobenfy™) in Schizophrenia: A Systematic and Meta-Analysis Review of Randomized Controlled Trials. | Psychiatr Q | 2025 | https://conductscience.org/library/papers/41045433 | PubMed |
| 40735384 | Does Dysregulation Of The Indirect Pathway Contribute To The Pathophysiology Of Catatonia Through Neurotransmitter Imbalance? | Clin Neuropsychiatry | 2025 | https://conductscience.org/library/papers/40735384 | PubMed |
| 40671308 | From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medications. | CNS Spectr | 2025 | https://conductscience.org/library/papers/40671308 | PubMed |
| 39768939 | Exploring Cognitive Deficits and Neuromodulation in Schizophrenia: A Narrative Review. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39768939 | PubMed |
| 39199294 | What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199294 | PubMed |
| 38904739 | Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment. | Clin Drug Investig | 2024 | https://conductscience.org/library/papers/38904739 | PubMed |
| 36414626 | Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study. | Transl Psychiatry | 2022 | https://conductscience.org/library/papers/36414626 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADRA2B | 151 | PubTator's text mining | https://conductscience.org/library/genes/151 | NCBI Gene |
| CHRFAM7A | 89832 | PubTator's text mining | https://conductscience.org/library/genes/89832 | NCBI Gene |
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 | NCBI Gene |
| ITIH1 | 3697 | PubTator's text mining | https://conductscience.org/library/genes/3697 | NCBI Gene |
| TAAR1 | 134864 | PubTator's text mining | https://conductscience.org/library/genes/134864 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36973270
GET https://conductscience.org/api/papers/v1/36973270/references?page=2